TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z, Ingle JN, Hartmann L, Jenkins RB, Couch FJ.
Sinclair CS, et al. Among authors: schaid d.
Cancer Res. 2002 Jul 1;62(13):3587-91.
Cancer Res. 2002.
PMID: 12097257